Maria Triana-Escobar
Pediatrics · Brownsville, TXNPI 1154876894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 9.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $595 and has fallen 56.7% since, to $257 in 2025. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$141
- Kowa Pharmaceuticals America, Inc.$124
- Merck$116
- Lilly USA, LLC$95
- Amgen$84
- Neurocrine Biosciences, Inc.$78
- plus $909 from 24 others
What the payments were for
- Food & beverage$1,546100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $141 |
| Kowa Pharmaceuticals America, Inc. | 1 | $124 |
| Merck | 6 | $116 |
| Lilly USA, LLC | 5 | $95 |
| Amgen(2 entities) | 5 | $84 |
| Neurocrine Biosciences, Inc. | 2 | $78 |
| Eisai Inc. | 3 | $76 |
| Amarin Pharma, Inc. | 4 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $67 |
| Boehringer Ingelheim | 4 | $62 |
| Nestle Healthcare Nutrition Inc. | 3 | $61 |
| Novo Nordisk | 3 | $57 |
| Seqirus USA Inc | 2 | $50 |
| Corium, LLC | 4 | $50 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| SK Life Science, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Biogen | 2 | $39 |
| UCB, Inc. | 1 | $35 |
| Hologic Sales And Service, LLC | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $27 |
| Abbott | 1 | $20 |
| Bayer | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Aucta Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Alk-abello, Inc | 1 | $14 |
| Neos Therapeutics, LP | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZORYVE$124
How this compares
$1,546 in reported general payments places this provider in the 90th percentile of 5,361 pediatrics providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 35 | $1,076 |
| Memantine Hcl | 18 | $584 |
| Gabapentin | 47 | $551 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 22 | $513 |
| Donepezil Hcl | 51 | $469 |
| Quetiapine Fumarate | 41 | $336 |
| Duloxetine Hcl | 16 | $212 |
| Cyclobenzaprine Hcl | 14 | $159 |
| Buspirone Hcl | 20 | $87 |
| Nortriptyline Hcl | 13 | $85 |
| Methocarbamol | 23 | $84 |
| Meclizine Hcl | 12 | $81 |
| Propranolol Hcl | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Brownsville
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
- Ralph DeberardinisDallas$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.